Literature DB >> 33408075

Response to: 'Correspondence on 'Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management'' by Snarskaya and Vasileva.

Cosimo Bruni1, Marco Matucci-Cerinic2,3.   

Abstract

Entities:  

Keywords:  COVID-19; biological therapy; scleroderma; systemic

Year:  2021        PMID: 33408075     DOI: 10.1136/annrheumdis-2020-219533

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  Impact of Covid-19 on clinical care and lived experience of systemic sclerosis: An international survey from EURORDIS-Rare Diseases Europe.

Authors:  Michael Hughes; John D Pauling; Andrew Moore; Jennifer Jones
Journal:  J Scleroderma Relat Disord       Date:  2021-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.